Corporate History

1947 Establishment of Daiichi Pure Chemical Co., Ltd.
Start of domestic production of in vitro diagnostic reagents.
2008 Establishment of Sekisui Medical Co., Ltd. (Sekisui Medical Co., Ltd. was formed after the Medical Business Division of Sekisui Chemical Co., Ltd. was merged with Daiichi Pure Chemical Co., Ltd.)
Sekisui Chemical Co., Ltd. acquired 100% of the shares of XenoTech, LLC in the U.S. State of Kansas.
2010 Establishment of Sekisui Medical Technology (China) through the merger of Beijing Sekisui Trank Medical Technology Co., Ltd. (Sekisui Chemical's subsidiary company) and Shanghai Daiichi Diagnostics Co., Ltd (Sekisui Medical's subsidiary company).
2011 Sekisui Chemical Co. Ltd. acquired the Diagnostic Pharmaceuticals Division of Genzyme Corporation in the U.S. State of Massachusetts and established Sekisui Diagnostics, LLC.
2015 Sekisui Chemical Co. Ltd. acquired 100% of the shares of EIDIA Co., Ltd.
Establishment of Sekisui Medical Technology (Suzhou) Co., Ltd. by Sekisui Chemical Co., Ltd.
2017 Sekisui Chemical Co. Ltd. merged Sekisui Medical Co., Ltd. and EIDIA Co., Ltd.
Establishment of PeptiStar Inc. through a joint venture agreement between PeptiDream Inc., Shionogi & Co., Ltd. and Sekisui Chemical Co., Ltd.
2018 Sekisui Chemical Co., Ltd. acquired Veredus Laboratories Pte. Ltd. in Singapore.